1,2-Dichloroethane → HCID 59375005、化合物
反応式
[C:1]([C:4]1[CH:5]=[CH:6][C:7]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=2[F:26])=[C:8]2[C:16]=1[NH:15][C:14]1[CH:13]=[C:12]([C:17](O)=[O:18])[CH:11]=[CH:10][C:9]2=1)(=[O:3])[NH2:2].C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.[CH3:50][N:51]1[CH2:56][CH2:55][CH:54]([NH2:57])[CH2:53][CH2:52]1>C1COCC1.CN(C=O)C>[F:26][C:21]1[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=1[C:7]1[C:8]2[C:9]3[C:14](=[CH:13][C:12]([C:17]([NH:57][CH:54]4[CH2:55][CH2:56][N:51]([CH3:50])[CH2:52][CH2:53]4)=[O:18])=[CH:11][CH:10]=3)[NH:15][C:16]=2[C:4]([C:1]([NH2:2])=[O:3])=[CH:5][CH:6]=1参加物
実験手順
A mixture of 8-carbamoyl-5-(2-fluorophenyl)-9H-carbazole-2-carboxylic acid (Example 23-2, 30 mg, 0.086 mmol), EDC (23.11 mg, 0.121 mmol), HOBT (18.46 mg, 0.121 mmol), DIEA (30 μL, 0.172 mmol), and 1-methylpiperidin-4-amine (9.83 mg, 0.086 mmol) in THF and DMF (4:1, 2 mL) was stirred at rt overnight. The mixture was concentrated and purified by preparative HPLC. The isolated product was partitioned between DCM and NaHCO3 (aq). The organic phase was dried and concentrated to provide 4-(2-fluorophenyl)-N7-(1-methylpiperidin-4-yl)-9H-carbazole-1,7-dicarboxamide as a white solid (25 mg, 62%). 1H NMR (400 MHz, DMSO-d6) δ 11.75 (s, 1H) 8.24 (br. s., 1H) 8.20 (s, 1H) 8.13 (d, J=7.69 Hz, 1H) 8.05 (d, J=7.91 Hz, 1H) 7.52-7.68 (m, 3H) 7.33-7.48 (m, 3H) 7.13 (d, J=7.69 Hz, 1H) 7.05 (d, J=8.35 Hz, 1H) 3.64-3.80 (m, 1H) 2.69-2.79 (m, 2H) 1.87-2.00 (m, 2H) 1.70-1.80 (m, 2H) 1.48-1.65 (m, 2H). Mass spectrum m/z 445.2 (M+H)+.
後処理
- concentrationThe mixture was concentrated
- custompurified by preparative HPLC
- customThe isolated product was partitioned between DCM and NaHCO3 (aq)
- customThe organic phase was dried
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-7c00a63ef34d45ff98571a681ba2da3b
- 出典データセット
- uspto-grants-2011_12
- 特許番号
- US08084620B2
反応ノート
読み込み中…